 |
| Lori Moore |
Germany's Bayer has brought on Lori Moore as VP & head of pharmaceutical communications in the US.
Moore moves to Bayer from Deloitte, where she most recently served as managing director, leading the company’s efforts to transform its internal communications.
Prior to joining Deloitte, she held communications leadership positions at Novo Nordisk and Sanofi.
At Bayer, Moore will be responsible for developing and executing external and internal communication strategies for the company’s pharmaceutical portfolio in the U.S., with a specific emphasis on cardiology, oncology, women’s health, hematology and radiology.
“Her impressive knowledge and expertise will help us advance our communications about the company’s pharmaceutical business here in this country,” said Ray Kerins, Bayer senior VP of corporate affairs.
Havilah Clarke, head of marketing and communications at the Huntsman Mental Health Foundation and Institute, has joined Purposeful Advisors as a managing director.
How purpose-driven communications strengthens reputation, rallies stakeholders and builds value during economically turbulent times.
Why healthcare must prioritize more strategic communications integration.
How the rules of the game are being rewritten in today’s turbulent health advocacy communications environment.
